{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:19:44Z","timestamp":1770481184393,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.dld.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T00:20:01Z","timestamp":1204849201000},"page":"433-440","source":"Crossref","is-referenced-by-count":36,"title":["Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study"],"prefix":"10.1016","volume":"40","author":[{"given":"H.","family":"Hanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kageoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ikeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kikuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Iwaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.01.007_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0016-5085(78)90285-8","article-title":"Macrophage turnover in Crohn's disease and ulcerative colitis","volume":"74","author":"Meuret","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/gut.35.5.669","article-title":"Increased macrophage subsets in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes","volume":"35","author":"Rugtveit","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.01.007_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ibd.3780060105","article-title":"The key role of macrophages in the immunopathogenesis of inflammatory bowel disease","volume":"6","author":"Mahida","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","article-title":"Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study","volume":"1","author":"Hanai","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2008.01.007_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","article-title":"Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease","volume":"86","author":"McCarthy","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00024382-200005000-00003","article-title":"Neutrophil apoptosis is delayed in patients with inflammatory bowel disease","volume":"13","author":"Brannigan","year":"2000","journal-title":"Shock"},{"key":"10.1016\/j.dld.2008.01.007_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jlb.54.4.283","article-title":"Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators","volume":"54","author":"Lee","year":"1993","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.dld.2008.01.007_bib9","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoids on the rate of appoptosis in neutrophilic and eosinophilic granulocytes","volume":"156","author":"Meagher","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1023\/A:1005521212948","article-title":"Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease","volume":"45","author":"D\u2019Odorico","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0016-5085(94)90614-9","article-title":"Cytokines in intestinal inflammation: pathophysiological and clinical considerations","volume":"106","author":"Sartor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","article-title":"Role of cytokines in the pathogenesis of inflammatory bowel disease","volume":"51","author":"Papadakis","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.dld.2008.01.007_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1023\/A:1010659803912","article-title":"IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis","volume":"46","author":"Lampinen","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1471-4906(02)00013-3","article-title":"IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation","volume":"24","author":"Kaplanski","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.dld.2008.01.007_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","article-title":"Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease","volume":"119","author":"Tibble","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib16","series-title":"Inflammatory bowel disease. Basic research, clinical implications and trends in therapy","first-page":"53","article-title":"Intestinal permeability: the basics","author":"Bjarnason","year":"1994"},{"key":"10.1016\/j.dld.2008.01.007_bib17","series-title":"Inflammatory bowel disease","first-page":"9","year":"1998"},{"key":"10.1016\/j.dld.2008.01.007_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/gut.42.4.470","article-title":"Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation","volume":"42","author":"Nikolaus","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.01.007_bib19","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1023\/A:1020159932758","article-title":"Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis","volume":"47","author":"Hanai","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","article-title":"The production of cytokines by polymorphonuclear neutrophils","volume":"16","author":"Cassatella","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.dld.2008.01.007_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0167-5699(97)01087-6","article-title":"Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis","volume":"18","author":"Edwards","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.dld.2008.01.007_bib22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimens for severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.01.007_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0016-5085(83)90323-2","article-title":"Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis: a prospective, randomized, double blind clinical trial","volume":"85","author":"Meyers","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","article-title":"Intensive intravenous treatment of ulcerative colitis","volume":"89","author":"Jarnerot","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00004836-198808000-00003","article-title":"Corticosteroids in ulcerative colitis: a skeptical review","volume":"10","author":"Babb","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01296907","article-title":"Sulphasalazine-adverse effects and desensitization","volume":"28","author":"Taffet","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib27","doi-asserted-by":"crossref","unstructured":"Present DH. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 2000;6:48\u201357.","DOI":"10.1097\/00054725-200002000-00009"},{"key":"10.1016\/j.dld.2008.01.007_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1526-0968.2003.00049.x","article-title":"Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis","volume":"7","author":"Hiraishi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.dld.2008.01.007_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.20046","article-title":"Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?","volume":"20","author":"Saniabadi","year":"2005","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2008.01.007_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1525-1594.1997.tb00513.x","article-title":"Granulocytapheresis in the treatment of patients with rheumatoid arthritis","volume":"21","author":"Ohara","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.dld.2008.01.007_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-9987.1998.tb00091.x","article-title":"A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis","volume":"2","author":"Kashiwagi","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.dld.2008.01.007_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1744-9987.1998.tb00082.x","article-title":"Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect","volume":"2","author":"Rembacken","year":"1998","journal-title":"Ther Apher"},{"key":"10.1016\/j.dld.2008.01.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.dld.2008.01.007_bib34","first-page":"117","article-title":"Granulocytapheresis in active ulcerative colitis. A multicenter randomized control study","volume":"18","author":"Shimoyama","year":"1999","journal-title":"Jpn J Apher"},{"key":"10.1016\/j.dld.2008.01.007_bib35","first-page":"640","article-title":"Cyclosporine enemas for treatment-resistant, mildly to moderately active left-sided ulcerative colitis","volume":"88","author":"Rachmilewitz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000080079","article-title":"Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid dependent moderately severe ulcerative colitis","volume":"70","author":"Hanai","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.01.007_bib37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis","volume":"120","author":"D\u2019Haens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Claudio","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/gast.2001.22122","article-title":"Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ectotherapeutics","volume":"120","author":"Shanahan","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib40","first-page":"81","article-title":"The state of the art in the management of inflammatory bowel disease","volume":"3","author":"Hanauer","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.dld.2008.01.007_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(98)03339-X","article-title":"Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease","volume":"353","author":"Schreaiber","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. NOVII","key":"10.1016\/j.dld.2008.01.007_bib42","first-page":"A57","article-title":"Adacolumn apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse","volume":"54","author":"Maiden","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.01.007_bib43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.01.007_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","article-title":"Intensive intravenous regimen foe severe attacks of ulcerative colitis","volume":"1","author":"Truelove","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.01.007_bib45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","article-title":"Intensive intravenous treatment of ulcerative colitis","volume":"89","author":"Jarnerot","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid na\u00efve patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00054725-200405000-00012","article-title":"Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis","volume":"10","author":"Naganuma","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.dld.2004.08.004","article-title":"Evaluation of granulocyte\/monocyte apheresis therapy for active ulcerative colitis","volume":"36","author":"Kanke","year":"2004","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2004.02189.x","article-title":"Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.01.007_bib50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","article-title":"A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis","volume":"51","author":"Suzuki","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00054725-200608000-00008","article-title":"Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings","volume":"12","author":"Yamamoto","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib52","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib53","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3748\/wjg.v12.i21.3393","article-title":"Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with ulcerative colitis","volume":"12","author":"Hanai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14712598.6.5.453","article-title":"The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease","volume":"6","author":"Kanai","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.dld.2008.01.007_bib55","doi-asserted-by":"crossref","unstructured":"Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006;21:7568\u201377 [Editorial].","DOI":"10.3748\/wjg.v12.i47.7568"},{"key":"10.1016\/j.dld.2008.01.007_bib56","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00535-004-1465-z","article-title":"Granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study","volume":"39","author":"Fukuda","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.dld.2007.02.003","article-title":"Leukocytapheresis as promising therapy for inflammatory bowel disease","volume":"39","author":"Caprilli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.dld.2007.01.010","article-title":"Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients","volume":"39","author":"Takemoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.dld.2007.03.007","article-title":"Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?","volume":"39","author":"Pan\u00e9s","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.dld.2007.01.001","article-title":"Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study","volume":"39","author":"Bresci","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.dld.2007.04.007","article-title":"Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis","volume":"39","author":"Yamamoto","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib62","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00042737-200409000-00023","article-title":"Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis","volume":"16","author":"Premchand","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.01.007_bib63","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","article-title":"Granulocyte aphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study","volume":"20","author":"Domenech","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2008.01.007_bib64","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.3748\/wjg.v11.i44.7001","article-title":"Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis","volume":"28","author":"Kruis","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00384-005-0069-2","article-title":"Downregulation of interferon-\u03b3 parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease. A 12-month follow-up study","volume":"21","author":"Muratov","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.gastro.2004.11.024","article-title":"Treating ulcerative colitis without medications\u2014\u201cLook Mom, No Drugs!\u201d","volume":"128","author":"Cohen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004836-200607000-00005","article-title":"Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease","volume":"40","author":"Sands","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.01.007_bib68","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1185\/030079907X233241","article-title":"Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte\/monocyte apheresis","volume":"23","author":"Schwartz","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2008.01.007_bib69","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.MIB.0000195387.26892.22","article-title":"Preliminary data on the use of apheresis in inflammatory bowel disease","volume":"12","author":"Sandborn","year":"2006","journal-title":"Bowel Dis"},{"key":"10.1016\/j.dld.2008.01.007_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.1995.tb03620.x","article-title":"Human neutrophil Fc receptor-mediated adhesion under flow: a hallow fiber model of intravascular arrest","volume":"100","author":"D\u2019Arrigo","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.01.007_bib71","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s10620-006-9406-8","article-title":"Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8 and the expression of toll like receptor 2 on granulocytes","volume":"52","author":"Aoki","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib72","first-page":"295","article-title":"The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease","volume":"160","author":"Heimann","year":"1985","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.dld.2008.01.007_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(94)90159-7","article-title":"Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial","volume":"107","author":"Lerebours","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.01.007_bib74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leucocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transf Apher Sci"},{"key":"10.1016\/j.dld.2008.01.007_bib75","doi-asserted-by":"crossref","unstructured":"Hanai H, Iida T, Watanabe F, Yamada M, Takeuchi K, Kikuyama M, et al. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008 [Epub ahead of print].","DOI":"10.1111\/j.1572-0241.2007.01714.x"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865808000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:52:16Z","timestamp":1684273936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865808000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1590865808000273"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.01.007","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}